Compare Fortune Mate Indonesia Tbk (FMII) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fortune Mate Indonesia Tbk vs Tempo Scan Pacific Tbk. — how do they compare? Fortune Mate Indonesia Tbk trades at Rp252 (market cap 1.59T, 4.7K 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,780 (market cap 12.58T, 235.2K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 7.9× Fortune Mate Indonesia Tbk's market cap, and Tempo Scan Pacific Tbk. is more actively traded (235.2K versus 4.7K). Which is the better fit depends on your goals.
| FMII | TSPC | |
|---|---|---|
Market Cap | 1.59T | 12.58T |
Volume | 4.7K | 235.2K |
Lot | 47 | 2.35K |
Turnover | 1.17M | 649.94M |
Average Price | 248.43 | 2,763.37 |
Value | 1.17M | 649.94M |
Indicative Equilibrium Price | 248 | 2,780 |
Indicative Equilibrium Volume | 200 | 9 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fortune Mate Indonesia Tbk
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Read more on FMII →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
